[synthesis.]Internal

Regulatory intelligence — not medical or legal advice.

Appearance
Active: dark
Accent
Corner radius
Font
Layout
Data refresh

Runs once per app session in the background and keeps existing data if source APIs are unavailable.

Annotation style
Ask · OpenAI

Requires OPENAI_API_KEY on the server. Heuristics always run first.

← Disease database

TFAP2B-related congenital heart disease spectrum disorder

Any congenital heart disease caused by pathogenic variation(s) in the TFAP2B gene, which encodes the transcription factor AP-2β. This disorder is characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies. Additional features include sensorineural hearing loss, scoliosis, dental anomalies, and central diabetes insipidus. Given the spectrum of symptoms associated with this condition, patients may exhibit a combination of these features.

Therapeutic area
Cardiovascular · Rare Disease
Rarity
Rare
Prevalence
~100k patients (est.)
MONDO
MONDO:1010098

Overview

Any congenital heart disease caused by pathogenic variation(s) in the TFAP2B gene, which encodes the transcription factor AP-2β. This disorder is characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies. Additional features include sensorineural hearing loss, scoliosis, dental anomalies, and central diabetes insipidus. Given the spectrum of symptoms associated with this condition, patients may exhibit a combination of these features.

The underlying mechanism of the spectrum disorder is both dominant negative and loss-of-function. Pathogenic missense variants reported in Char syndrome patients appear to be dominant negative while loss-of-function alleles in PDA patients are likely to act through haploinsufficiency.

Content last reviewed: 2026-06